STOCK TITAN

Agios Pharmaceuticals: D. E. Shaw reports 6.5% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Agios Pharmaceuticals, Inc. (AGIO) is the issuer whose common stock D. E. Shaw & Co., L.P. and David E. Shaw each report beneficial ownership of 3,888,907 shares, equal to 6.5% of the class. The amendment identifies September 30, 2026, as the event date. The reporting persons report shared voting power over 3,607,007 shares and shared dispositive power over 3,888,907 shares, with no sole voting or dispositive power. David E. Shaw states that he owns no shares directly and disclaims beneficial ownership.

Beneficial ownership 3,888,907 shares Reported by each reporting person; David E. Shaw disclaims beneficial ownership.
Ownership of class 6.5% Reported by each reporting person.
Shared voting power 3,607,007 shares Reported by each reporting person.
Shared dispositive power 3,888,907 shares Reported by each reporting person.
Sole voting power 0 shares Reported by each reporting person.
Sole dispositive power 0 shares Reported by each reporting person.
beneficial ownership regulatory
"Aggregate Amount Beneficially Owned by Each Reporting Person"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
shared voting power regulatory
"Shared Voting Power 3,607,007.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power regulatory
"Shared Dispositive Power 3,888,907.00"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many AGIO shares did D. E. Shaw report beneficially owning?

D. E. Shaw & Co., L.P. and David E. Shaw each reported beneficial ownership of 3,888,907 AGIO shares, equal to 6.5% of the class. David E. Shaw says he owns no shares directly and disclaims beneficial ownership.

How many AGIO shares did D. E. Shaw report shared voting and disposition power over?

The reporting persons reported shared voting power over 3,607,007 shares and shared dispositive power over 3,888,907 shares. They reported no sole voting or dispositive power.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





00847X104

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



D. E. Shaw & Co., L.P.
Signature:/s/ Daniel R. Marcus
Name/Title:Daniel R. Marcus / Chief Compliance Officer
Date:11/16/2026
David E. Shaw
Signature:/s/ Daniel R. Marcus
Name/Title:Daniel R. Marcus / Attorney-in-Fact for David E. Shaw
Date:11/16/2026

Comments accompanying signature: Exhibit 1: Power of Attorney, granted by David E. Shaw relating to D. E. Shaw & Co., Inc., in favor of the signatories hereto, among others, dated August 1, 2024.
Exhibit Information

Exhibit 2: Joint Filing Agreement, by and among the Reporting Persons, dated November 16, 2026.

Keep reading